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Storage using BDM or Blebbistatin Preserves Functional Measures of
Unloaded Cardiomyocytes
Charles S. Chung, Charles Mechas, Kenneth S. Campbell.
University of Kentucky, Lexington, KY, USA.
Intact isolated cardiomyocytes are used to investigate the molecular mecha-
nisms of contraction and to screen new therapeutic compounds. Typically,
these studies require either daily isolation or culture of cardiomyocytes, which
either costs investigators time and animals or alters myocyte function and
morphology. Recently, investigators reported preserving canine cardiomyocyte
function using N-benzyl-p-toluene sulphonamide (BTS), a skeletal muscle
myosin ATPase inhibitor. We investigated the preservation of rat cardiomyo-
cyte function using the common cardiac cross-bridge inhibitors 2,3-Butane-
dione monoxime (BDM), a phosphatase, and Blebbistatin, a selective myosin
ATPase. We isolated cardiomyocytes from 6 mo old female Sprague Dawley
rats. The isolate was divided for use over multiple days and storage conditions.
Functional measurements (calcium transients and sarcomere length (SL)
twitches) were obtained in a Tyrodes solution at 25C beginning on the day
of isolation (Day 0). Cells used on Days 1-4 post isolation were stored in a
HEPES buffered solution with 0.5mM Cat(2þ) at 4C: (1) without additional
cross-bridge inhibitors (control), (2) þ10mM BDM, and (3) þ3mM Blebbista-
tin. Control (inhibition-free) cells showed reduced SL (<1.7mm diastolic),
membrane blebbing, and altered functional measurements (calcium transients
and SL twitches) within 24 hours. Cells stored in BDM maintained function
for 24 hours but exhibited reduced diastolic SL and significant blebbing at
48 hours. Cells stored in blebbistatin showed excellent maintenance of diastolic
SL and cell membrane quality more than 4 days post isolation. Calcium tran-
sients did not change after 4 days of storage in blebbistatin, but SL shortening
was attenuated after 24 hrs. UV light exposure deactivated blebbistatin inhibi-
tion and restored SL shortening back to Day 0 magnitudes. Storage of rodent
cardiomyocytes may help investigators reduce, replace, or refine experiments
by allowing extended use of cardiomyocytes from single isolations.
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As more and more cardiomyopathy causing mutations are identified, functional
studies investigating contractility and myofilament mechanics with mutated
proteins become more crucial. Several methods are available, but most rely
on exchanging recombinant protein into permeabilized heart cells or myofila-
ment preparation. However, success requires large amounts of highly purified
myofilament proteins, a process which is usually different for each individual
protein. Here, we describe one single method that can be used for purifying
myofilament protein, including troponin T, I and C, as well as myosin light
chain 2, which has also been adapted to other recombinant proteins. We fuse
a HIS-tag and a modified tobacco etch virus (TEV) protease cleavage site, EN-
LYFQ/M, to the N- terminal of our protein construct. The flexibility of P1’ res-
idue of the TEV protease cleavage site allows substitution of the native glycine
to a methionine, enabling production of unmodified forms of protein after pu-
rification. We then express recombinant protein constructs in BL21 (DE3)
E.coli competent cells which are lysed in buffer containing 6 M Urea. Clarified
lysate is then applied to a HisTrap nickel affinity column. Following a low con-
centration of imidazole wash, the protein is then eluted with high imidazole,
and the elution buffer is replaced by a high salt protease digestion buffer using
a desalting column. Protease digestion is performed at 4C overnight, and any
undigested protein and the protease itself are removed by a second run on a Hi-
sTrap, allowing the purified recombinant protein to be collected. A final desalt-
ing step allows us to store the protein in a variety of solutions according to
experimental needs. Overall, this method significantly increases yield and ac-
celerates purification process from almost a week to only two days.
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Introduction/Methods: Inherited mutations in cardiac thin filament proteins
lead to changes in protein structure and dynamics. This results in the pathological
tissue remodeling seen in patients with hypertrophic (HCM) and dilated (DCM)cardiomyopathies. Our group is interested in the alpha-Tm D230N mutation
known to cause DCM and the cardiac troponin T (cTnT) mutation R92L which
causes HCM. To investigate effects of these mutations on the tropomyosin (Tm)
head-to-tail overlap we used Forster Resonance Energy Transfer (FRET). For
both wild-type and mutants, Tm was labeled at site 271 with DDPM, cTnT
was labeled with IAEDANS at site 100. Labeled cTnT was reconstituted into
troponin complex (Tn) and combined with Tm along with actin to form the re-
constituted thin filament. Time-resolved data was acquired and analyzed.
Results/Conclusions: Both R92L and D230Nmutants result in a change in dis-
tance between labeled sites of cTnT andTmwhen compared towild-type. Trans-
fer efficiency decreased from 0.78 to 0.66 upon addition of the D230Nmutation,
representing an increased distance between the labeled sites. However, the trans-
fer efficiency increased from 0.78 to 0.80 in the presence of the R92L mutation,
supporting a decreased distance between the labeled sites. This differentialmod-
ulation of the distancemay reflect alterations in the interaction between the cTnT
and Tm proteins due to these mutations. This supports the hypothesis that these
mutations which cause different clinical phenotypes are having opposite effects
in the region of interest. Ongoing experiments utilizing site 60 of cTnT, and sites
262 and 279 of Tmwill provide additional information about the similar and dif-
ferential effects of these mutants on the Tm overlap region.
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Duchenne Muscular Dystrophy (DMD) is a wasting disease of striated muscle
resulting from membrane fragility. We modeled DMD cardiac disease using
urine-derived cells from a patient, reprogrammed to induced pluripotent stem
cells (hiPSCs) and differentiated into cardiomyocytes (DMD-hiPSC-CMs).
DMD-hiPSC-CMs were dystrophin-deficient (exon 50 deletion) and manifested
physiological consequences of the disease such as calcium-handling abnormal-
ities. Here we report, for the first time, isolation and functional characterization
of myofibrils from hiPSC-CMs to study DMD cardiomyopathy.
At day 20 post-differentiation, DMD-hiPSC-CMs and control hiPSC-CMs (from
a healthy volunteer) were replated onto fibronectin-coated nanopatterned cover-
slides and cultured until day 80. Both DMD- and controls-CMs exhibited more
mature morphology with aligned myofibrils and clearly defined Z-bands, cell
lengths of 100-150mm and widths of 40mm. For mechanical measurements, cells
were harvested and skinned in a rigor solution containingTriton 1%for 5minutes.
Control hiPSC-CM myofibrils had mechanical and kinetic proporties more
similar to human fetal skeletal (Racca, 2013) or cardiac myofibrils than human
adult cardiac myofibrils. Preliminary data for DMD-hiPSC-CMs showed lower
force development, prolonged duration of early, slow phase relaxation kinetics
(tREL slow), but no differences in the other kinetic properties. Preliminary data
from intact DMD-hiPSC-CMs paced at 1Hz showed no difference in the rate
of cell shortening, but depressed magnitude and prolonged relaxation (t50).
We previously reported (Xuan G, 2014) prolongation of Ca2þ transient decay.
Together these data suggest DMD-hiPSC-CMs have slower relaxation due to
both myofibril properties and Ca2þ sequestration, compared with control
hiPSC-CMs, and both cell lines have myofibril mechanic and kinetic properties
more similar to fetal than adult myofibrils.
In conclusion, we demonstrated that isolated functional myofibrils from hiPSC-
CMs can be obtained after growing on nano-patterned surfaces in culture to
study cardiac diseases in vitro.Smooth Muscle Mechanics, Structure, and
Regulation
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